Michael Lee Stallard

SEPTEMBER 16, 2015

Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. Developing this ownership culture will be key to our success. We engaged with leaders across the business and sought the candid input of approximately 11,000 colleagues globally. I am personally proud of Pfizer’s colleagues.

Ethics 150

Ethics Pharmaceuticals Globalization Commitment 150

Strategy Driven

AUGUST 18, 2021

Plenty of proactive companies are shifting and adjusting their operations to incorporate sustainable practices. Improved operations and lower expenses. Smart energy utilization will enable your business to curb inflating energy costs and achieve operational efficiency. Enhanced corporate social responsibility.

Pharmaceuticals 123

Pharmaceuticals Energy Fashion Apparel 123

Strategy Driven

JUNE 22, 2020

When countries impose strong lockdown curfews on their citizens, only businesses deemed “essential” are allowed to operate as normal. Logistics play a vital role in the functioning and development of any nation’s infrastructure. Pharmaceuticals. Vehicle Maintenance. Delivery Services.

Pharmaceuticals 65

Pharmaceuticals Insurance Industry Transportation 65

The Horizons Tracker

JUNE 9, 2021

The authors argue that it isn’t necessary for the public to understand how AI works in order for them to trust it, but they do need to know that someone with the knowledge to examine and understand how it’s operating has the authority to oversee it and sanction its developers if it begins to cause harm.

Document 87

Document Pharmaceuticals Discount Technology 87

Marshall Goldsmith

NOVEMBER 4, 2013

” Their ideal leader is a person who develops “win-win” relationships and is sensitive to their needs for personal growth and development. Leaders will need to develop skills in negotiation and “win-win” relationships. In return, they feel a responsibility to deliver value back.

Short-term 107

Short-term Long-term Trends Report 107

HR Digest

FEBRUARY 24, 2023

Operations Coordinator, Software Development Industry Save Costs Working remotely has the added benefit of saving both the employee and the employer money. HR Manager, Pharmaceutical Industry Leverage Technology To ensure the success of a remote work policy, HR professionals must leverage technology effectively.

Guidelines 100

Guidelines Policies Cost Pharmaceuticals 100

Talent Anarchy 1

AUGUST 25, 2023

Pharmaceuticals: Medicines and healthcare products are also considered consumer non-durables. Product Development and Innovation For those who enjoy creativity and problem-solving, a career in product development and innovation within the consumer non-durables industry can be incredibly rewarding.

Career 60

Career Supply Chain Pharmaceuticals Industry 60

The Horizons Tracker

FEBRUARY 22, 2022

billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. It’s a market that is already worth $3.1 “With 5G, you get fast upload speeds, up to 100Gbsp on many public networks.

Stephenson 109

Stephenson Wireless Christensen Automotive 109

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 51

Tactics Execution Pharmaceuticals Human Capital 51

Chartered Management Institute

MAY 17, 2023

Now director of corporate transformation services at Alvarez & Marsal – the corporate turnaround consulting firm best known for handling the Lehman Brothers’ bankruptcy – Emma has an executive MBA from Cranfield, worked for pharmaceutical giant GSK, and cut her leadership teeth in the Royal Navy. “

Leadership 59

Leadership How To Pharmaceuticals Resources 59

Strategy Driven

JULY 13, 2011

Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Strategy Driven

NOVEMBER 29, 2016

Intensive training and a well-understood chain of command may have instilled in veterans a respect for authority and a commitment to duty, but this was not to the exclusion of their development as leaders. Bill Sebra is Chief Operations Executive at Korn Ferry Futurestep. Attracting former service members is only half the battle.

Agility 50

Agility Pharmaceuticals Self-aware Learning-by-Doing 50

Strategy Driven

JANUARY 24, 2011

Plus, as a result of a lack of cross-organizational coordination and cooperation, Nokia wasn’t able to improve its proprietary operating system, Symbian, which would have allowed it to support a more sophisticated smartphone. Many innovative ideas became the victims of in-fighting among managers who had competing objectives.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 15

Competitive Advantage Globalization Development Intellectual Capital 15

Strategy Driven

MARCH 18, 2011

In addition, we believe that your starting point for strategy development is what you are already great at, rather than studying the industry and market for opportunities. Is it more important to consider capabilities when you develop a strategy now than it was, say, five years ago? SD : Why now? What do most companies do instead?

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

MARCH 21, 2012

Surprisingly, one was running operations in supposedly macho Iberia (Spain and Portugal), the other in China. A whopping 80% of graduating doctors are female too, turning the medical profession into a female sector not necessarily reflected in the big pharmaceutical or medical devices company that try and serve them.

Pharmaceuticals 17

Pharmaceuticals Maturity Education Objective 17

Harvard Business Review

MAY 16, 2011

But for many years it took a hands-off approach to new product development — dictating needs, but letting vendors bid for a slot on the Sun server and sink or swim after that. The Sun-Netscape Alliance was formed when AOL acquired Netscape in 1998 but then sought to spin out the software operations of Netscape.

Software 19

Software Licensing Long-term Telecommunications 19

Harvard Business Review

FEBRUARY 21, 2014

A Zurich-born manager with 10 years’ experience working in Germany and Switzerland, Xavier had just landed a few days ago in Monterrey, Mexico, at a small pharmaceutical company that was recently purchased by Xavier’s company, a major European pharmaceutical firm.

Pharmaceuticals 14

Pharmaceuticals Globalization Operations Motivation 14

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. In the process, I came up with six rules that could also help others change their cultures.

Company 13

Company Pharmaceuticals Biotechnology Short-term 13

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. In a new research paper , I tease apart the factors associated with the growth in corporate valuations relative to assets ( Tobin’s Q ) and the growth in operating margins. Profits are up. Corporate valuations are up as well.

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 14

COO Sample Telecommunications Automotive 14

Harvard Business Review

FEBRUARY 17, 2011

The interesting part of this shift is that VCs are taking a more holistic or "systems" approach to investing than they typically do in developed markets. Because of three significant challenges innovators face in emerging markets: Innovation ecosystems are not well-developed. Why do VCs in emerging markets take a systems approach?

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

FEBRUARY 22, 2011

Everyone" includes primary care doctors, medical specialists, nurses, hospital administrators, health insurance providers, nutritionists, pharmaceutical companies, medical technology manufacturers, fitness gurus, paraprofessionals, public health commissioners, and charities dedicated to a disease.

Health Care 16

Health Care Innovation Pharmaceuticals Consensus 16

Harvard Business Review

OCTOBER 6, 2016

Investments in traditional leadership development are often misguided and a waste of money. It’s not that development itself isn’t important. So they’re looking for ways to cultivate those competencies and, in the process, feeding the fad-driven leadership development market. Paul Garbett for HBR.

Leadership Pipeline 15

Leadership Pipeline Leadership After Action Review Pharmaceuticals 15

Harvard Business Review

JULY 8, 2016

Entrepreneurs in Chinese industries from animated media to applied medical research said that China’s insistence on domestic standards are resulting in less-ambitious innovation and that the education system is not supporting appropriate talent development.

Business Model 14

Business Model Innovation Company Apparel 14

Harvard Business Review

MARCH 11, 2013

At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. It had to pump up the buzz around its platform to encourage its current customers to stay loyal and developers to make apps. Over time, openness tends to win out in the market.

Supply Chain 16

Supply Chain Open-book Software Niche Marketing 16

Harvard Business Review

SEPTEMBER 26, 2011

The market favorably receives projects with long-term payoffs, particularly those in research and development. But they would have also undermined our efforts to create new drugs, which typically take 10 to 15 years to develop, hurting the company and the people who depend on us to find new therapies over the long term. I disagree.

CEO 17

CEO Short-term Long-term Pharmaceuticals 17

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families.

Health Care 14

Health Care Retail Operations Insurance 14

Harvard Business Review

SEPTEMBER 29, 2011

They are not interested in hearing about the technological, regulatory, and societal developments that will determine the long-term, strategic positioning of this company.". Correspondingly, as a small group of firms have done, companies should stop issuing guidance for short-term earnings to the investment community.

Long-term 14

Long-term CEO Short-term Asset Management 14

Harvard Business Review

JULY 7, 2011

Many of the best leaders and managers in the business world operate from the Pleaser power style. When they are operating from their strengths, Pleasers can become the glue that holds a positive corporate culture together. Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser.

Rogers 16

Rogers Morale Long-term Pharmaceuticals 16

Harvard Business Review

NOVEMBER 29, 2018

In this article, I’d like to share the insights we’ve gleaned from the model’s first full year of operation, which hopefully organizations in health care and many other industries will find useful. Our clinics reported the early development of the disease in huddles.

Health Care 14

Health Care System Metrics Report 14

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. Information & technology Operations Organizational culture Product development'

Productivity 10

Productivity Products Company Engineering 10

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. They will not, it must be noted, alter how the role of manufacturing evolves as economies develop.

Globalization 12

Globalization Supply Chain Pharmaceuticals McKinsey 12

Harvard Business Review

AUGUST 3, 2016

Regulators try to model how prices, sales, and even the combining parties’ research and development efforts will change after a merger. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

JUNE 27, 2012

Paul is an old friend who, until his recent retirement, worked as a senior scientist at a pharmaceutical company, where he managed a group of innovative researchers. Because of the start-up's success in developing drugs, it was acquired by a large multinational company.

COO 13

COO Short-term Pharmaceuticals Innovation 13

Harvard Business Review

OCTOBER 23, 2014

Used to its full potential, this is predictive medicine — the ability to integrate and analyze known disease characteristics with a specific patient’s history and health status, and use the resulting insights to change outcomes and inform new directions for life sciences research and development. They’re also sharing risk.

Health Care 9

Health Care Pharmaceuticals Information Technology Supply Chain 9

Harvard Business Review

NOVEMBER 1, 2017

million adults in the United States with high blood sugar levels in danger of developing type 2 diabetes. Weight loss is a clinically-accepted proxy measure for reducing the risk of developing diabetes.) Diabetes is one of the most pervasive and expensive chronic diseases: It affects an estimated 30.3 In addition there are 84.1

Health Care 17

Health Care Participative Wireless Pharmaceuticals 17